Alto Neuroscience , Inc. (NYSE:ANRO), a pharmaceutical company currently trading at $4.18 per share, has entered into a Sales Agreement with Leerink Partners LLC, initiating an "at the market" ...

Operating income was $6.2 million in the first quarter of fiscal 2025, compared to $9.7 million in the prior year period. This led to net earnings in Q1 ’25 of $5.1 million, compared to $7.3 million ...

Ipsos maintains strong cash flows and continues strategic acquisitions despite recent guidance cuts on organic revenue. Click ...

MicroStrategy stock's performance is driven by its bitcoin yield strategy. See why MSTR is part of a growing trend of ...

Corporation (NASDAQ: FRME) reported its fourth-quarter earnings for 2024, surpassing analysts' expectations with an earnings per share (EPS) of $1.00, adjusted from $1.10, against a forecast of $0.89.

Intel stock is struggling for direction Friday after the chipmaker reported a fourth-quarter beat but gave weak guidance.

Gentex Corporation (NASDAQ: GNTX), a leading supplier of digital vision, connected car, dimmable glass and fire protection technologies, today reported financial results for the fourth quarter and ...

The company reported a net loss for the fourth quarter 2024 of $603 million, or $1.87 per share. During the quarter, the ...

The domestic benchmark index, Nifty, opened flat, maintained buying interest, and settled the day on a positive note at ...

Following is the text of European Central Bank President Christine Lagarde's statement after the bank's policy meeting on Thursday: ...

Fed rate decision, stock market updates: Dow, Nasdaq, S&P 500 slip, Nvidia falls as Fed leaves rates unchanged ...

Microsoft spent $22.6bn on capital expenditure in the second quarter of the year, as mammoth spending on artificial intelligence persists. The Seattle-based group said in a blog post earlier this ...